SNY Stock Price, Chart, Stats & News

Sanofi ADR
Save
SNY chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 72.34% |
Operating margin | 13.58% |
Pretax margin | 12.89% |
Net margin | 16.72% |
Effective tax rate | 17.33% |
ROA | 6.16% |
ROE | 10.82% |
D/E | 0.28x |
Interest coverage ratio | 11.73x |
SNY valuation
P/E | 18.33x |
P/S | 2.11x |
P/B | 1.39x |
P/CF | 10.65x |
P/FCF | 11.93x |
P/OCF | 10.65x |
PEG | -0.31x |
EV multiple | 6.79x |
About
Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, development, production, and distribution of a wide array of therapeutic solutions across the United States, Europe, and numerous international markets. The company strategically organizes its operations into three core divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare. Within its Pharmaceutical segment, Sanofi delivers specialized therapies, including innovative human monoclonal antibodies, addressing complex conditions like multiple sclerosis, various neurological disorders, immunology and inflammatory diseases, oncology, rare diseases, and rare blood disorders.
Similar securities
Based on sector and market capitalization
Report issue











